この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
エネルギーと環境 · 1995/1/41 分で読めます
Preparation, Transfer for Commercial Distribution, and Use of Byproduct Material for Medical Use
ローカル自動翻訳 · 情報源の原言語
概要
The Nuclear Regulatory Commission (NRC) is amending regulatory text and the response to a public comment contained in a final rule published in the Federal Register on Friday, December 2, 1994, entitled "Preparation, Transfer for Commercial Distribution, and Use of Byproduct Material for Medical Use." This action is necessary following reconsideration by the NRC regarding the requirements for the information to be included on labels for radioactive drugs to be transferred for commercial distribution. The effect of this action is to reduce regulatory burden and uncertainty for licensees that manufacture and distribute radiopharmaceuticals that contain byproduct material for medical use.
情報源の原言語: Federal Register — Nuclear Regulatory Commission原文の発表を開く →